- Home
- TRTX vs NAGE Comparison
TRTX vs NAGE Comparison
Compare TRTX & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRTX
- NAGE
- Stock Information
- Founded
- TRTX 2014
- NAGE 1999
- Country
- TRTX United States
- NAGE United States
- Employees
- TRTX N/A
- NAGE N/A
- Industry
- TRTX Real Estate Investment Trusts
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- TRTX Real Estate
- NAGE Health Care
- Exchange
- TRTX Nasdaq
- NAGE Nasdaq
- Market Cap
- TRTX 685.3M
- NAGE 766.4M
- IPO Year
- TRTX 2017
- NAGE N/A
- Fundamental
- Price
- TRTX N/A
- NAGE $7.39
- Analyst Decision
- TRTX Buy
- NAGE Strong Buy
- Analyst Count
- TRTX 3
- NAGE 3
- Target Price
- TRTX $9.50
- NAGE $17.00
- AVG Volume (30 Days)
- TRTX 796.4K
- NAGE 1.2M
- Earning Date
- TRTX 10-28-2025
- NAGE 10-30-2025
- Dividend Yield
- TRTX 11.07%
- NAGE N/A
- EPS Growth
- TRTX N/A
- NAGE N/A
- EPS
- TRTX 0.65
- NAGE 0.22
- Revenue
- TRTX $138,587,000.00
- NAGE $116,303,000.00
- Revenue This Year
- TRTX N/A
- NAGE $28.91
- Revenue Next Year
- TRTX $6.77
- NAGE $20.89
- P/E Ratio
- TRTX $13.34
- NAGE $34.52
- Revenue Growth
- TRTX 216.02
- NAGE 35.90
- 52 Week Low
- TRTX $6.47
- NAGE $3.18
- 52 Week High
- TRTX $9.85
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- TRTX 40.92
- NAGE 33.77
- Support Level
- TRTX $8.47
- NAGE $7.00
- Resistance Level
- TRTX $8.76
- NAGE $7.60
- Average True Range (ATR)
- TRTX 0.14
- NAGE 0.55
- MACD
- TRTX -0.03
- NAGE -0.21
- Stochastic Oscillator
- TRTX 28.03
- NAGE 15.68
About TRTX TPG RE Finance Trust Inc.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.